LINCOMYL 500MG TABLETS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE

Available from:

ARKOLETTE PTY LTD

INN (International Name):

lincomycin as HCl(500mg/Tb)

Pharmaceutical form:

ORAL TABLET

Composition:

LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE ANTIBIOTIC Active 500.0 mg/Tb

Units in package:

100 Tb

Class:

VM - Veterinary Medicine

Manufactured by:

RIVERSIDE VET PRODS

Therapeutic group:

DOG | BITCH | CASTRATE | PUPPY

Therapeutic area:

ANTIBIOTIC & RELATED

Therapeutic indications:

CANINE DISTEMPER | INFECTIONS OF THE SKIN | INFECTIONS OF UPPER RESPIRATORY TRACT | LARYNGITIS | METRITIS | PUSTULAR DERMATITIS | SECONDARY INFECTION | STAPHYLOCOCCI | STREPTOCOCCI | TONSILLITIS | WOUND INFECTIONS | ABSCESSES | ANAL SACCULITIS | FUNGAL | GINGIVITIS | GRAM NEGATIVE BACTERIA | GRAM POSITIVE BACTERIA | INCLUDING B-LACTAMASE PRODUCIN | POST-PARTURIENT INFECTIONS | PYODERMA | SECONDARY BACTERIAL INFECTIONS | SECONDARY BACTERIAL INVADERS | SECONDARY INFECTION TO VIRUS | SEPTICAEMIA | YEAST

Product summary:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [CANINE DISTEMPER, INFECTIONS OF THE SKIN, INFECTIONS OF UPPER RESPIRATORY TRACT, LARYNGITIS, METRITIS, PUSTULAR DERMATITIS, SECONDARY INFECTION, STAPHYLOCOCCI, STREPTOCOCCI, TONSILLITIS, WOUND INFECTIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [CANINE DISTEMPER, INFECTIONS OF THE SKIN, INFECTIONS OF UPPER RESPIRATORY TRACT, LARYNGITIS, METRITIS, PUSTULAR DERMATITIS, SECONDARY INFECTION, STAPHYLOCOCCI, STREPTOCOCCI, TONSILLITIS, WOUND INFECTIONS]; For the treatment of infections due to lincomycin susceptible gram positive organisms including upper respiratory tract infections, skin diseases and infected wounds in dogs.

Authorization status:

Registered

Authorization date:

2023-07-01